PRESS RELEASE For Immediate Release/VACCINE EXPOSURES TO THIMEROSAL (MERCURY) &

[Guest guest]

COMED INC.

14 REDGATE COURT,

SILVER SPRING, MD 20905-5726

VACCINE EXPOSURES TO THIMEROSAL (MERCURY) & PREMATURE PUBERTY

PRESS RELEASE

For Immediate Release

May 1, 2010

CONTACTS:

CoMeD President [Rev. K. Sykes (Richmond, VA) 804-364-8426]

CoMeD Sci. Advisor [Dr. G. King (Lake Hiawatha, NJ) 973-997-1321]

WASHINGTON, DC – A new study, " Thimerosal Exposure & Increasing Trends of

Premature Puberty in the Vaccine Safety Datalink " , published in the most recent

issue of the peer-reviewed Indian Journal of Medical Research , confirms a

significant association in American children between an increasing rates of

premature puberty and increasing exposure to mercury from Thimerosal-containing

childhood vaccines.

Premature puberty (or precocious puberty) is characterized by sexual

developmental before the age of eight in girls, and age 10 in boys. While the

early onset of puberty may seem fairly benign, in fact, it can cause problems

when hormones trigger changes in growth patterns. Further, children with the

condition may feel rejected by their friends and socially isolated. Many of

these children, especially the boys, are much more aggressive than others of

their own age, leading to behavioral problems both at home and at school.

During the past decade, possible advancement in timing of puberty has been

reported in the US. Recently, attention has been paid to the possible role of

endocrine-disrupting chemicals on the timing of puberty. The US Agency for Toxic

Substances and Disease Registry (ATSDR) of the US Centers for Disease Control

and Prevention (CDC) reported that mercury is a known endocrine disruptor and it

adversely affects the steroid synthesis pathway in animals and humans.

Over the last several decades, many infants received significant exposure to

mercury from Thimerosal-containing childhood vaccines in the US. Thimerosal, an

organic mercury-containing compound that is 49.55% mercury by weight, is

initially metabolized in vivo into ethylmercury compounds and thiosalicylate.

This new study evaluated the relationship between mercury exposure from

Thimerosal-containing childhood vaccines and the risk of a child's being

diagnosed with premature puberty by a physician in a cohort of 278,624 subjects

in the CDC's Vaccine Safety Datalink (VSD) database who were born in 1990-1996.

Significantly increased rate ratios were observed for premature puberty for a

100-µg difference in mercury exposure from Thimerosal-containing childhood

vaccines in the birth-7 months (rate ratio=5.58) and birth-13 months (rate

ratio=6.45) of age exposure windows. Further, the observed overall prevalence

rate for premature puberty was about one in 250 children. This represents a

significant (about 40-fold) increase in the diagnosed rate of premature puberty

of about one in 10,000 children reported in prior government estimates.

Consistent with the results of this new study, in the early 1950s with pink

disease, now known to be primarily caused by the use of mercurous chloride

(Calomel) in teething powders and other drugs given to infants, children with a

" pink disease " diagnosis were also commonly found to have altered states of

adrenocorticol secretion, excessive production of androgen hormones, and

pseudohermaphroditism.

The investigators concluded, " …the results of the present study show an

association between increased Hg exposure from Thimerosal-containing vaccines

and premature puberty. The observed effects were consistent with the known human

endocrine disrupting effects of [mercury] Hg exposure…[and] efforts should be

undertaken to remove Thimerosal from all vaccines as rapidly as possible… "

This landmark study was supported by the not-for-profit 501© 3 corporations:

CoMeD, Inc and the Institute of Chronic Illnesses, Inc, and by the Autism

Petitioners' Steering Committee of the no-fault National Vaccine Injury

Compensation Program (NVICP).

Your generous tax-free donations will help us to fund additional research,

similar to the present study.

To support the ongoing efforts of CoMeD, Inc. with your tax-deductible

contributions, please use the PayPal link on CoMeD's Internet website,

http://www.Mercury-freeDrugs.org. CoMeD, Inc. is a not-for-profit 501©(3)

corporation that is actively engaged in legal, educational and scientific

efforts to stop all use of mercury in medicine, and to ban the use of all

mercury-containing medicines.

[1] Geier DA, Young HA, Geier MR Thimerosal Exposure & Increasing Trends of

Premature Puberty in the Vaccine Safety Datalink. Indian Journal of Medical

Research 2010; 131: 500-507.